KOCAA
ITCI
Knights of Columbus Asset Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-22,533
| Closed | -$1.65M | – | 423 |
|
|
2024
Q3 | $1.65M | Sell |
22,533
-21,848
| -49% | -$1.6M | 0.11% | 203 |
|
|
2024
Q2 | $3.04M | Buy |
44,381
+7,517
| +20% | +$515K | 0.2% | 170 |
|
|
2024
Q1 | $2.55M | Sell |
36,864
-17,635
| -32% | -$1.22M | 0.18% | 176 |
|
|
2023
Q4 | $3.9M | Buy |
54,499
+27,331
| +101% | +$1.96M | 0.25% | 175 |
|
|
2023
Q3 | $1.42M | Buy |
27,168
+3,464
| +15% | +$180K | 0.13% | 223 |
|
|
2023
Q2 | $1.5M | Buy |
23,704
+52
| +0.2% | +$3.29K | 0.13% | 218 |
|
|
2023
Q1 | $1.28M | Buy |
23,652
+146
| +0.6% | +$7.91K | 0.13% | 224 |
|
|
2022
Q4 | $1.24M | Buy |
23,506
+12,016
| +105% | +$636K | 0.13% | 218 |
|
|
2022
Q3 | $535K | Buy |
11,490
+1,367
| +14% | +$63.7K | 0.05% | 240 |
|
|
2022
Q2 | $578K | Buy |
+10,123
| New | +$578K | 0.06% | 244 |
|